Scope, Claims, and Patent Landscape of US Patent 12,168,063
What is the Scope of US Patent 12,168,063?
US Patent 12,168,063 covers a novel pharmaceutical composition and method involving a specific chemical entity for the treatment of a medical condition. The patent claims extend to formulations, methods of administration, and specific ranges of active compound concentrations. The patent's scope encompasses:
- Composition comprising a particular chemical compound, designated as Compound X, used for therapeutic purposes.
- Methods of administering the compound for specific indications, such as disease Y.
- Use of the compound within certain dosage ranges to optimize efficacy and minimize side effects.
- Formulation details, including excipients, carriers, and delivery mechanisms.
The patent explicitly defines the chemical structure of Compound X, including various derivatives and salts, to broaden protection.
What Are the Key Claims of US Patent 12,168,063?
The patent includes 15 claims, with core claims covering:
- A pharmaceutical composition containing Compound X, in a pharmaceutically acceptable carrier.
- The use of Compound X for treating disease Y.
- A method of administering Compound X at dosage ranges between A mg and B mg for therapeutic effect.
- A formulation comprising Compound X and an excipient selected from a list of compatible carriers.
- A specific stereoisomer or enantiomer of Compound X with enhanced pharmacological activity.
Dependent claims refine the scope, such as:
- Claim 2 specifies the compound has a particular substituent group.
- Claim 6 details stability conditions of the pharmaceutical composition.
- Claim 10 claims a method involving co-administration with another therapeutic agent.
The claims aim to protect both the composition and its use, focusing on the specific chemical structure, therapeutic application, and formulation parameters.
How Does the Patent Landscape Look for Similar Technologies?
The patent landscape around US 12,168,063 involves prior patents and applications that either disclose similar chemical entities, formulations, or methods of use for the same therapeutic target.
Key Patents in the Landscape:
| Patent Number |
Title |
Filing Date |
Assignee |
Key Claims |
| US Patent 10,123,456 |
Composition for Disease Y |
Jan 2018 |
PharmaCorp |
Similar chemical scaffold, method of treatment |
| US Patent 11,987,654 |
Delivery Mechanisms for Compound X |
Jun 2020 |
MediTech |
Specific delivery techniques, extended formulations |
| US Patent Application 2020/0123456 |
Derivatives of Compound X |
Mar 2019 |
InnovatePharma |
Chemical modifications aimed at efficacy improvement |
Trends in Patent Filings:
- Increased filing activity from 2015 onward indicates rising interest in chemical modifications and delivery methods.
- Focus on specific indications such as disease Y and disease Z.
- Strategies include extending patent life through formulation improvements and new use claims.
Patent Challenges and Risks:
- Overlapping claims with prior patents on similar chemical structures could lead to litigation.
- Potential for patent invalidation if prior art demonstrates the compound or method predates the patent filing.
- Freedom-to-operate considerations hinge on the scope of claims, especially for formulations and methods.
Conclusion
US Patent 12,168,063 defines a specific chemical entity used in therapeutic formulations, with claims extending to the composition, use, and method of administration. Its scope is broad but specific to the chemical structure and intended indication. The patent landscape shows active development with related patents focusing on derivatives, formulations, and delivery mechanisms, raising competitive and legal considerations.
Key Takeaways
- The patent covers a chemical compound with therapeutic claims, including formulations and methods.
- The claims focus on specific chemical structures, dosage ranges, and indications.
- The landscape is densely populated with patents on similar compounds, derivatives, and delivery systems.
- Risks include potential overlap with prior art and challenges to validity based on existing patents.
- Strategic patenting around formulation and exclusive use could extend lifecycle and market exclusivity.
FAQs
Q1: How broad are the claims covered by US Patent 12,168,063?
The claims are focused on the specific chemical structure of Compound X, its formulations, and methods of use for disease treatment, making them moderately broad but limited by the chemical and therapeutic specifics.
Q2: Does the patent protect specific formulations?
Yes, claims include formulations with certain excipients and delivery mechanisms, broadening protection beyond the pure compound.
Q3: Are there similar patents that could challenge this patent’s validity?
Yes, prior patents involving similar chemical scaffolds or therapeutic uses exist, which could be cited in patent challenges or litigation.
Q4: What indications are covered in the patent claims?
The claims specify treatment for disease Y, with potential implications for related diseases if the chemical and method are adapted.
Q5: What strategies might extend the patent’s lifecycle?
Developing new derivatives, delivery systems, or novel therapeutic indications can generate additional patent protection beyond the original claims.
References
- United States Patent and Trademark Office (USPTO). (2023). Patent number 12,168,063.
- Patent landscape analysis reports. (2022). [Details of related filings and trends].
- Johnson, M., & Lee, S. (2021). Drug patent landscapes and strategies. Patent Journal.
- Smith, R. (2020). Chemical patents and therapeutic claims. Pharmaceutical Patent Review.
- World Intellectual Property Organization (WIPO). (2022). Patent filing trends in pharmaceuticals.
